Compile Data Set for Download or QSAR
Report error Found 184 Enz. Inhib. hit(s) with all data for entry = 12490
TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706362(US20240383900, Compound PPA-024)
Affinity DataIC50: 6nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706422(US20240383900, Compound PPA-086)
Affinity DataIC50: 11nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706428(US20240383900, Compound PPA-092)
Affinity DataIC50: 13nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706362(US20240383900, Compound PPA-024)
Affinity DataIC50: 17nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706400(US20240383900, Compound PPA-064)
Affinity DataIC50: 18nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706354(US20240383900, Compound PPA-016)
Affinity DataIC50: 22nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706410(US20240383900, Compound PPA-074)
Affinity DataIC50: 23nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706426(US20240383900, Compound PPA-090)
Affinity DataIC50: 23nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706421(US20240383900, Compound PPA-085)
Affinity DataIC50: 23nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706425(US20240383900, Compound PPA-089)
Affinity DataIC50: 28nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706375(US20240383900, Compound PPA-037)
Affinity DataIC50: 28nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706401(US20240383900, Compound PPA-065)
Affinity DataIC50: 29nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706385(US20240383900, Compound PPA-047)
Affinity DataIC50: 31nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706429(US20240383900, Compound PPA-093)
Affinity DataIC50: 31nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706387(US20240383900, Compound PPA-049)
Affinity DataIC50: 32nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706419(US20240383900, Compound PPA-083)
Affinity DataIC50: 32nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706409(US20240383900, Compound PPA-073)
Affinity DataIC50: 33nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706340(US20240383900, Compound PPA-002)
Affinity DataIC50: 34nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706408(US20240383900, Compound PPA-072)
Affinity DataIC50: 34nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706343(US20240383900, Compound PPA-005)
Affinity DataIC50: 34nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706348(US20240383900, Compound PPA-010)
Affinity DataIC50: 36nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706356(US20240383900, Compound PPA-018)
Affinity DataIC50: 39nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706407(US20240383900, Compound PPA-071)
Affinity DataIC50: 40nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706413(US20240383900, Compound PPA-077)
Affinity DataIC50: 41nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706404(US20240383900, Compound PPA-068)
Affinity DataIC50: 42nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706418(US20240383900, Compound PPA-082)
Affinity DataIC50: 44nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706364(US20240383900, Compound PPA-026)
Affinity DataIC50: 45nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706341(US20240383900, Compound PPA-003)
Affinity DataIC50: 47nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706392(US20240383900, Compound PPA-054)
Affinity DataIC50: 49nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706345(US20240383900, Compound PPA-007)
Affinity DataIC50: 51nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706344(US20240383900, Compound PPA-006)
Affinity DataIC50: 51nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706382(US20240383900, Compound PPA-044)
Affinity DataIC50: 51nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706346(US20240383900, Compound PPA-008)
Affinity DataIC50: 52nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706373(US20240383900, Compound PPA-035)
Affinity DataIC50: 52nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706391(US20240383900, Compound PPA-053)
Affinity DataIC50: 53nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706347(US20240383900, Compound PPA-009)
Affinity DataIC50: 55nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706417(US20240383900, Compound PPA-081)
Affinity DataIC50: 57nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706369(US20240383900, Compound PPA-031)
Affinity DataIC50: 60nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706424(US20240383900, Compound PPA-088)
Affinity DataIC50: 60nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706339(US20240383900, Compound PPA-001)
Affinity DataIC50: 61nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706367(US20240383900, Compound PPA-029)
Affinity DataIC50: 63nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706403(US20240383900, Compound PPA-067)
Affinity DataIC50: 65nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706359(US20240383900, Compound PPA-021)
Affinity DataIC50: 69nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706357(US20240383900, Compound PPA-019)
Affinity DataIC50: 70nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706360(US20240383900, Compound PPA-022)
Affinity DataIC50: 72nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706352(US20240383900, Compound PPA-014)
Affinity DataIC50: 72nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706352(US20240383900, Compound PPA-014)
Affinity DataIC50: 74nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706341(US20240383900, Compound PPA-003)
Affinity DataIC50: 76nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706397(US20240383900, Compound PPA-060)
Affinity DataIC50: 77nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 12(Human)
Carrick Therapeutics

US Patent
LigandPNGBDBM706363(US20240383900, Compound PPA-025)
Affinity DataIC50: 78nMAssay Description:A radiometric protein kinase assay (33PanQinase® Activity Assay) was used for measuring the kinase activity of the two protein kinases (CDK12/CDK7). ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

Displayed 1 to 50 (of 184 total ) | Next | Last >>
Jump to: